HDAC6 and BET co-inhibition synergistically blocked phosphorylation of AKT and p65, which positively correlates with HNSCC malignancy [32], without changing total ATK and p65 levels (Figure 4C,D). The gene discussed is HDAC6; the disease is head and neck squamous cell carcinoma.